Veraxa Biotech AG - Post de-SPAC VRXA
NASDAQ VRXA
$1.00 -0.03 (-2.91%)
At close: Oct 23, 2026 · 4:00 PM EDT

Veraxa Biotech AG - Post de-SPAC (VRXA) Liabilities and Shareholders Equity (2024 - 2025)

Updated

Veraxa Biotech AG - Post de-SPAC (VRXA) posted Liabilities and Shareholders Equity of $101.12 million for the quarter ended Dec 31, 2025, up 4.5% from $96.76 million a year earlier.

Analysis

Veraxa Biotech AG - Post de-SPAC (VRXA) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends

As of Dec 31, 2025, Veraxa Biotech AG - Post de-SPAC's Liabilities and Shareholders Equity came in at $97.48 million, up 1.2% from the prior year.

  • In prior years, Veraxa Biotech AG - Post de-SPAC's Liabilities and Shareholders Equity was $96.35 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 197.43 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 135.12 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 115.83 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 49.36 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 201.13 Bn
10 Veraxa Biotech AG - Post de-SPAC 14.47 Mn 10.90 Mn - 102.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 102.21 Mn
Dec 31, 2024 93.85 Mn
API Access

Veraxa Biotech AG - Post de-SPAC Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VRXA&period=max&api_key=YOUR_API_KEY